301 related articles for article (PubMed ID: 34357126)
21. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
22. Probiotics, prebiotics and amelioration of diseases.
Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
[TBL] [Abstract][Full Text] [Related]
23. Novel molecular profiles of endometrial cancer-new light through old windows.
Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
[TBL] [Abstract][Full Text] [Related]
24. Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.
Ahmadi S; Mainali R; Nagpal R; Sheikh-Zeinoddin M; Soleimanian-Zad S; Wang S; Deep G; Kumar Mishra S; Yadav H
Obes Control Ther; 2017; 4(3):. PubMed ID: 30474051
[TBL] [Abstract][Full Text] [Related]
25. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
26. Probiotics, prebiotics and colorectal cancer prevention.
Ambalam P; Raman M; Purama RK; Doble M
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
[TBL] [Abstract][Full Text] [Related]
27. The Influence of the Gut Microbiome on Obesity in Adults and the Role of Probiotics, Prebiotics, and Synbiotics for Weight Loss.
Aoun A; Darwish F; Hamod N
Prev Nutr Food Sci; 2020 Jun; 25(2):113-123. PubMed ID: 32676461
[TBL] [Abstract][Full Text] [Related]
28. [The Relationship between Gut Microbiome, Immune System, and Cancer].
Ichikawa M; Sujino T; Kanai T
Gan To Kagaku Ryoho; 2019 Dec; 46(12):1807-1813. PubMed ID: 31879393
[TBL] [Abstract][Full Text] [Related]
29. Preventing Colorectal Cancer through Prebiotics.
Mahdavi M; Laforest-Lapointe I; Massé E
Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34207094
[TBL] [Abstract][Full Text] [Related]
30. Role of Gut Microbiota in Type 2 Diabetes Mellitus and Its Complications: Novel Insights and Potential Intervention Strategies.
Woldeamlak B; Yirdaw K; Biadgo B
Korean J Gastroenterol; 2019 Dec; 74(6):314-320. PubMed ID: 31870137
[TBL] [Abstract][Full Text] [Related]
31. Classical methods and perspectives for manipulating the human gut microbial ecosystem.
Jiménez-Avalos JA; Arrevillaga-Boni G; González-López L; García-Carvajal ZY; González-Avila M
Crit Rev Food Sci Nutr; 2021; 61(2):234-258. PubMed ID: 32114770
[TBL] [Abstract][Full Text] [Related]
32. The human-microbiome superorganism and its modulation to restore health.
Salvucci E
Int J Food Sci Nutr; 2019 Nov; 70(7):781-795. PubMed ID: 30843443
[TBL] [Abstract][Full Text] [Related]
33. [Abnormal gut microbiota-induced hypoestrogenemia as a possible risk factor for malignancy in endometrioid heterotopia].
Ukrainets RV; Korneva YS; Dorosevich AE
Arkh Patol; 2020; 82(2):57-61. PubMed ID: 32307440
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota and inflammatory bowel disease: so far so gut!
Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
[TBL] [Abstract][Full Text] [Related]
35. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
36. The influence of gut microbiome on bone health and related dietary strategies against bone dysfunctions.
Peng J; Yu XJ; Yu LL; Tian FW; Zhao JX; Zhang H; Chen W; Zhai QX
Food Res Int; 2021 Jun; 144():110331. PubMed ID: 34053534
[TBL] [Abstract][Full Text] [Related]
37. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
[TBL] [Abstract][Full Text] [Related]
38. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet?
Knox NC; Forbes JD; Van Domselaar G; Bernstein CN
Curr Treat Options Gastroenterol; 2019 Mar; 17(1):115-126. PubMed ID: 30661163
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiome and cardiovascular disease.
Zhao Y; Wang Z
Curr Opin Cardiol; 2020 May; 35(3):207-218. PubMed ID: 32068612
[TBL] [Abstract][Full Text] [Related]
40. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
Schiattarella GG; Sannino A; Esposito G; Perrino C
Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
